Biopsy Devices Market: Growth, Size, Share, and Trends

Report Code MD 5504
Published in Mar, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030

Overview

The global biopsy devices market, valued at US$6.86 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$7.27 billion in 2024 and an impressive US$11.01 billion by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market. Underdeveloped healthcare infrastructure in emerging economies would challenge the growth of the biopsy device market across the forecast period.

Biopsy Device Market– Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Biopsy Device Market

Asia Pacific

The growth of the Biopsy devices market in the Asia Pacific region is driven by a combination of factors. lifestyle changes, has increased the prevalence of cancers and other chronic diseases in China, India, and Japan various initiatives undertaken by the government to manage early detection coupled with rising technological advancements and favorable healthcare expenditure in this region is expected to boost the demand for these devices.

The key factors driving market growth include the increasing incidence of cancers, often associated with aged population demographics, unhealthy lifestyles, require advanced treatments.

The high growth potential of emerging economies are expected to provide opportunities to market players during the forecast period.

The Asia pacific biopsy devices devices market is projected to reach USD 3,791.7 million by 2030, growing at a CAGR of 7.8% during the forecast period.

Stringent regulatory requirements for product approvals are expected to restrain the market growth to a certain extent.

Global Biopsy Device Market Dynamics

DRIVER: Rising Prevalence of Cancer

Biopsy is the gold standard for cancer diagnosis. With the increase of cancer at global level, coupled by aging population, lifestyle changes, and environmental factors, the need for early and accuracy in diagnosis is the need of the hour. According to the World Health Organization (WHO), cancer incidence is expected to rise by approximately 50% over the next two decades, leading to a higher number of biopsy procedures. Increasing cancer screening programs, as well as government campaigns for early diagnosis, further boost the use of biopsy devices. Moreover, advancements in targeted therapy and precision medicine needs tissue biopsies to profile them at a molecular and genetic level, allowing for individualized treatment strategies. The increased deployment of minimally invasive biopsy methods, including liquid biopsies and image-guided interventions, increases patient compliance and procedural productivity. Consequently, the rising cancer burden is a direct driver of the growth of the biopsy devices market.

RESTRAINT: Increasing product recalls

The market for biopsy devices is restrained by the increasing product recalls. This is due to the stringent regulatory rules imposed by the various governments such as FDA, CDSCO, and among others, as these devices are directly coming in contact of blood. The recalls significantly limit market expansion by undermining confidence of the customer, imposing added financial burden on manufacturers, and causing supply chain disruption. The recalls are caused by device malfunction, risk of contamination, or failure to meet regulatory requirements, resulting in concerns regarding patient safety. When biopsy devices are recalled, diagnostic centers and hospitals can shelve or eschew procuring similar equipment, anticipating adverse effects, lessening aggregate demand. Also, recalls cause regulatory oversight, obliging manufacturers to spend more money on compliance tests and product verifications, further adding costs and time to market new products. The economic effect goes beyond immediate losses since firms will also experience legal proceedings, compensation claims, and loss of reputation, further deterring investors and restricting market growth. In addition, recurrent recalls bring about uncertainty in the market, hindering technology uptake and innovation, as firms become wary of launching new biopsy devices.

 

OPPORTUNITY: Technological Advancements

Advances in technology offer a great chance for the expansion of the biopsy devices market. Robotics and AI-assisted biopsy systems, enable targeted biopsy of lesions with precision, less chance of false negatives, and fewer repeative procedures. Liquid biopsy technology, which involves the examination of circulating tumor DNA (ctDNA) or exosomes in blood samples, provides a less invasive alternative to standard tissue biopsies. This facilitates early cancer diagnosis and real-time monitoring of treatment response. Further, real-time navigation systems and 3D imaging, including ultrasound-guided and MRI-guided biopsy devices, enhance localization of suspicious tissue, with higher rates of procedural success. Further, advancements in vacuum-assisted and automated biopsy tools facilitate quick sample procurement with low tissue damage. Such advancements not only enhance diagnostic performance but also increase accessibility, which makes biopsies more secure, quicker, and available for a wider population, hence leading to growth in the market in the subsequent years.

CHALLENGES: Underdeveloped healthcare infrastructure in emerging economies

Underdevelopment of the healthcare infrastructure in emerging economies is a major drawback to the growth of the biopsy devices market. The unavailability of sophisticated medical technology and diagnostic centers results in delayed and improper disease detection. This would dampen the demand for biopsy procedures. Most healthcare systems in these countries lack proper funding, experienced medical practitioners, and have old machinery. This makes it hard to implement and incorporate advanced biopsy equipment. Furthermore, the cost of biopsy tests, combined with the absence of reimbursement policies, renders these diagnostics unaffordable to a vast majority of the population. Inadequate supply chain management and logistical issues also restrict the use of biopsy devices, especially in rural and outlying regions. Additionally, lower awareness and educational levels about cancer detection at the early stages cut down on demand for biopsy operations, further capping market growth. These must be addressed by making huge investments in healthcare facilities, training health workers, and policy changes.

Global Biopsy Device Market Ecosystem Analysis

The biopsy device market ecosystem includes manufacturers, healthcare providers, regulatory bodies, and end-users. Key players in the biopsy devices include medical device companies offering biopsy devices catering to the nedd of various patients. Regulatory authorities such as FDA, European Commission, CDSCO ensure product safety, while technological advancements (antimicrobial coatings, ultrasound-guided insertions) enhance patient outcomes. Hospitals, breast care centers are primary end-users, with reimbursement policies impacting adoption. Market consolidation, partnerships, and geographic expansions shape competition, with North America leading, while Asia-Pacific sees rapid growth due to healthcare infrastructure advancements. The ecosystem thrives on R&D investments, strategic collaborations, and evolving patient-centric innovations, ensuring sustained market evolution.

Biopsy Device Market
 

By Product, the needle based biopsy instrument segment accounts for the largest market share in biopsy device in 2023.

Based on product, the biopsy device market is divided into Needle based biopsy instrument, Visualization device, Brush biopsy instrument, Biopsy accessory and Robotic biopsy device. Among these, the needle based biopsy instrument holds the largest market share in 2023. Needle based biopsy are the most commonly used devices for cancer diagnosis, most notably breast, lung, prostate, and liver cancers. Needle biopsy devices such as core needle biopsy (CNB) and fine needle aspiration biopsy (FNAB) provide minimally invasive, low-cost, and high-accuracy tissue sampling with fewer patient discomfort and shorter recovery time. Increased usage of image-guided procedures like ultrasound-guided and CT-guided biopsies also creates a demand, driving the growth. Also, improvement in the design of the needle, as with vacuum-assisted biopsy systems, increases sample collection efficiency. The rising occurrence of cancer along with increased awareness about early detection also boosts growth.

By technology, the stereotactic guided biopsy holds the second largest share of the biopsy device market.

Based on technology, the biopsy device market is divided into ultrasound-guided biopsy, stereotactic guided biopsy and other technology. Among these, the ultrasound guided biopsy holds the second largest market share in 2023.This is because of its high accuracy, minimal invasiveness, and efficacy in the diagnosis of breast tumors. Stereotactic-guided biopsy employs sophisticated imaging modalities like mammography, CT, or MRI to identify suspicious lesions with high accuracy, minimizing the risk of unnecessary procedures. It is very useful in the diagnosis of cancers in their early stage, particularly microcalcifications within the breast, where conventional methods may not be very effective. Also, the increased demand for minimally invasive interventions, reduced recovery time, and fewer complications fuels this position in the market. Further, technological improvements through constant upgrades further improve its precision and efficiency.

By application, the oncology is the fastest growing segment in the biopsy device market.

Based on application, the biopsy device market is divided into oncology, gastroenterology, Bone & Bone Marrow Biopsy and other application. Among these, oncology is the fastest growing segment in the biopsy devices market in 2023. This is caused by increasing incidence of cancer, globally and heightened awareness for early cancer diagnosis. Advances in minimally invasive biopsy technology like liquid biopsy and image-guided biopsy have boosted diagnostic sensitivity and patient outcomes. This is further enhancing demand of biopsy devices. Higher investments in research on cancer, biomarkers, and personalized therapy also boost demand for biopsy. Further, the increasing use of robotic-assisted biopsy procedures and growth in healthcare infrastructure in emerging markets also drive the market.

By end user, Ambulatory surgical center holds a significant share of the biopsy device market.

Based on end users, the biopsy device market has been classified into hospitals & breast care center, diagnostic imaging center, ambulatory surgical center, and other end users. The Ambulatory surgical center segment accounted for a significant share in 2023. This is because they are cost-saving, convenient, and efficient in contrast to the traditional hospital environment. ASCs deliver same-day surgeries, decreasing hospitalization of patients and lowering total healthcare expenditure. The growing preference for minimally invasive treatments, including image-guided and vacuum-assisted biopsies, has further heightened the demand for ASCs. Besides, newer biopsy technologies, reduced recovery time, and low risks of infection make ASCs an enticing prospect for healthcare professionals as well as patients. Increased cancer workload and the importance of rapid accurate diagnoses further augment the use of biopsy procedures within ASCs.

The Asia Pacific is expected to show the highest growth in the biopsy device market over the forecast period.

The growing incidence of cancer, specifically breast, lung, and gastrointestinal cancers, is boosting the demand for early and precise diagnostics. Growing healthcare expenditure, better healthcare infrastructure, and government programs to improve cancer screening programs also aid market growth. Further, the increasing demand for minimally invasive procedures, complemented by advancements in imaging-guided biopsy methods, is also driving the demand. The large geriatric population, with increased vulnerability to cancer, is also supporting the growth of the market. Increased availability of global and regional medical device companies and increasing research and development investments is also fueling technological developments, which is leading to Asia-Pacific becoming a strong growth center for biopsy devices.

HIGHEST CAGR MARKET IN 2023
ASIA_PACIFIC FASTEST GROWING MARKET IN THE REGION
Biopsy Device Market

Recent Developments of Biopsy Device Market

  • In November 2024, Mammotome, a subsidiary of Devicor, launched the Mammotome AutoCore, which offers significant advantages over traditional core needle devices.
  • In August 2023, Mammotome, a subsidiary of Devicor, launched the HydroMARK Plus Breast Biopsy Site Marker. This product is a groundbreaking advancement that focuses on addressing tissue marker displacement.

Key Market Players

Want to explore hidden markets that can drive new revenue in Biopsy Devices Market?

Scope of the Report

Report Metric Details
Market size available for years 2024-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Value (USD Million/Billion)
Segments covered Product, Technology, Application, End User, and Region
Geographies covered North America (US & Canada), Europe (Germany, UK, France, Italy, Spain, nordic countries and RoE), Asia Pacific (Japan, China, Australia, South Korea, India, and the RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), Middle East & Africa (GCC Countries, RoMEA)

 

Key Questions Addressed by the Report

Which are the top industry players in the global biopsy device market?
The top market players in the global biopsy device market include BD (US), Devicor Medical Products, Inc. (US), Medtronic (Ireland), Cardinal Health (US), and Hologic, Inc. (US).
What are some of the major drivers for this market?
Growth in the biopsy device market can be attributed to factors such as the growing prevalence of cancer, increasing preference for minimally invasive procedures, and improved reimbursement policies.
Which end users have been included in the global vascular access device market?
The report includes the following end-user segments: Hospitals & Breast Care Centers, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Other End Users.
Which type of biopsy device is lucrative for the biopsy device market?
The needle-based biopsy instrument segment is expected to witness the highest growth during the forecast period.
Which region is lucrative for the biopsy device market?
The Asia Pacific market is expected to witness the highest growth during the forecast period.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Biopsy Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
42
RESEARCH METHODOLOGY
47
EXECUTIVE SUMMARY
59
PREMIUM INSIGHTS
64
MARKET OVERVIEW
68
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising prevalence of cancer
    - Increasing preference for minimally invasive surgeries
    - Initiatives undertaken by governments and global health organizations
    - Increased number of hospitals and diagnostic centers
    - Improved reimbursement policies
    RESTRAINTS
    - Increasing product recalls
    - High risk of infections
    OPPORTUNITIES
    - Technological advancements
    - Growing investments in emerging economies
    CHALLENGES
    - Underdeveloped healthcare infrastructure in emerging economies
  • 5.3 INDUSTRY TRENDS
    MINIMALLY INVASIVE PROCEDURES
    ROBOTIC-ASSISTED BIOPSY DEVICES
    LIQUID BIOPSY TECHNOLOGY
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Robotic-assisted biopsy devices
    - Optical biopsy technologies
    - Minimally invasive biopsy devices
    COMPLEMENTARY TECHNOLOGIES
    - Imaging technologies
    - Tissue analysis technologies
    - Artificial intelligence
    ADJACENT TECHNOLOGIES
    - Digital pathology and AI integration
    - Precision medicine tools
    - Advanced needle and probe technologies
  • 5.5 PORTER’S FIVE FORCES ANALYSIS
    THREAT FROM NEW ENTRANTS
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT FROM SUBSTITUTES
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.6 REGULATORY LANDSCAPE
    REGULATIONS, BY REGION
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East & Africa
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS IN BIOPSY DEVICES MARKET
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.8 TRADE ANALYSIS
  • 5.9 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT
    AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION
  • 5.10 KEY CONFERENCES & EVENTS
  • 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.12 BIOPSY DEVICES MARKET: UNMET NEEDS/EXPECTATIONS OF END USERS
  • 5.13 ECOSYSTEM ANALYSIS
  • 5.14 CASE STUDY ANALYSIS
    CASE STUDY 1: DEVICELAB COLLABORATED WITH CLINICAL EXPERTS TO IDENTIFY LIMITATIONS OF EXISTING BREAST BIOPSY PROCEDURES
    CASE STUDY 2: RESEARCHERS AT UNIVERSITY OF TWENTE DESIGNED ROBOTIC SETUP AND SOFTWARE ARCHITECTURE TO ASSIST RADIOLOGISTS IN TARGETING MRI-DETECTED SUSPICIOUS TUMORS
    CASE STUDY 3: RESEARCH TEAM DESIGNED FLEXIBLE ROBOTIC SYSTEM FOR BIOPSY SAMPLING APPLIED TO HUMAN CORPSES PLACED INSIDE PROTECTIVE BODY BAGS
  • 5.15 SUPPLY CHAIN ANALYSIS
  • 5.16 ADJACENT MARKET ANALYSIS
    BREAST BIOPSY DEVICES MARKET
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.18 INVESTMENT & FUNDING SCENARIO
  • 5.19 IMPACT OF AI ON BIOPSY DEVICES MARKET
BIOPSY DEVICES MARKET, BY PRODUCT
103
  • 6.1 INTRODUCTION
  • 6.2 NEEDLE-BASED BIOPSY INSTRUMENT
    CORE NEEDLE BIOPSY
    - Core needle biopsy device
    - Core needle biopsy needle
    FINE NEEDLE ASPIRATION BIOPSY
    - Innovations in needle design, including thinner profiles and improved tip configurations, to drive market
    VACUUM-ASSISTED BIOPSY
    - Increasing need for early and accurate cancer detection to drive market
  • 6.3 VISUALIZATION DEVICE/SYSTEM
    RISING PREVALENCE OF CANCER AND OTHER CHRONIC CONDITIONS TO DRIVE DEMAND FOR VISUALIZATION DEVICE
  • 6.4 BRUSH BIOPSY INSTRUMENT
    PREFERENCE FOR MINIMALLY INVASIVE BIOPSY PROCEDURES TO BOOST MARKET
  • 6.5 BIOPSY ACCESSORY
    BIOPSY FORECEP
    - General biopsy forcep
    - Hot biopsy forecep
    TISSUE MARKER
    - Rising cases of breast cancer to boost market growth
    LOCALIZATION WIRE
    - Ability of localization wire to detect precise target locations to drive growth
    OTHER ACCESSORIES
  • 6.6 ROBOTIC BIOPSY DEVICE
    RAPID DEVELOPMENT OF ROBOTIC BIOPSY DEVICES TO BOOST GROWTH
BIOPSY DEVICES MARKET, BY TECHNOLOGY
154
  • 7.1 INTRODUCTION
  • 7.2 ULTRASOUND-GUIDED BIOPSY
    ULTRASOUND GUIDANCE ENHANCES SAFETY, MINIMIZES COMPLICATIONS, AND IMPROVES DIAGNOSTIC ACCURACY
  • 7.3 STEREOTACTIC-GUIDED BIOPSY
    NEED FOR EFFICIENT AND ACCURATE BIOPSY PROCEDURES TO SUPPORT MARKET GROWTH
  • 7.4 OTHER TECHNOLOGIES
BIOPSY DEVICES MARKET, BY APPLICATION
162
  • 8.1 INTRODUCTION
  • 8.2 ONCOLOGY
    BREAST CANCER
    - Increasing demand for early and accurate diagnosis to boost growth
    SOFT TISSUE CANCER
    - Advancements in diagnostics and growing emphasis on cancer therapeutics to drive market
  • 8.3 GASTROENTEROLOGY
    RISING INCIDENCE OF GASTROINTESTINAL DISEASES TO DRIVE MARKET
  • 8.4 BONE & BONE MARROW BIOPSY
    RISING EMPHASIS ON BONE MARROW BIOPSIES TO SUPPORT MARKET GROWTH
  • 8.5 OTHER APPLICATIONS
BIOPSY DEVICES MARKET, BY END USER
177
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS & BREAST CARE CENTERS
    DEMAND FOR STATE-OF-THE-ART BIOPSY FACILITIES TO DRIVE MARKET
  • 9.3 DIAGNOSTIC IMAGING CENTERS
    INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH
  • 9.4 AMBULATORY SURGICAL CENTERS
    GROWING FOCUS ON AMBULATORY CARE TO DRIVE MARKET
  • 9.5 OTHER END USERS
BIOPSY DEVICES MARKET, BY REGION
189
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK
    US
    - Growth in elderly population to drive market
    CANADA
    - Rising government investments to drive growth
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK
    GERMANY
    - Increasing prevalence of chronic diseases to propel market
    UK
    - Initiatives by government to support market growth
    FRANCE
    - Rising number of diagnostic imaging centers to drive market
    ITALY
    - Availability of reimbursement coverage to support market growth
    SPAIN
    - Increasing focus on cancer research to propel market
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK
    CHINA
    - Rapidly growing geriatric population to propel market
    JAPAN
    - High adoption of advanced technologies to support market growth
    INDIA
    - Rising prevalence of chronic diseases to drive market
    AUSTRALIA
    - Increasing investments in research to provide opportunities for market growth
    SOUTH KOREA
    - Presence of well-developed healthcare systems to propel market
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK
    BRAZIL
    - Favourable demographic conditions to drive market
    MEXICO
    - Increased medical tourism and better government healthcare initiatives to drive market
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - Expansion of healthcare providers to drive growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
397
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Product footprint
    - Technology footprint
    - Application footprint
    - End user footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
COMPANY PROFILES
417
  • 12.1 KEY PLAYERS
    BD (BECTON, DICKINSON AND COMPANY)
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DEVICOR MEDICAL PRODUCTS, INC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MEDTRONIC
    - Business overview
    - Products offered
    - MnM view
    CARDINAL HEALTH
    - Business overview
    - Products offered
    - MnM view
    HOLOGIC, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    B. BRAUN SE
    - Business overview
    - Products offered
    OLYMPUS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    FUJIFILM CORPORATION
    - Business overview
    - Products offered
    STRYKER
    - Business overview
    - Products offered
    TELEFLEX INCORPORATED
    - Business overview
    - Products offered
    CONMED CORPORATION
    - Business overview
    - Products offered
    MERIT MEDICAL SYSTEMS
    - Business overview
    - Products offered
    JOHNSON & JOHNSON SERVICES, INC.
    - Business overview
    - Products offered
    COOK GROUP
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    MICROPORT SCIENTIFIC CORPORATION
    ARGON MEDICAL DEVICES
    INRAD, INC.
    SUMMIT MEDICAL LLC
    TRANSMED7, LLC
    DR. JAPAN CO., LTD.
    IZI MEDICAL PRODUCTS
    PLANMED OY
    ADVIN HEALTH CARE
    TRIVITRON HEALTHCARE
APPENDIX
495
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 BIOPSY DEVICES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATE, 2019–2024
  • TABLE 3 RESEARCH ASSUMPTIONS
  • TABLE 4 PORTER’S FIVE FORCES ANALYSIS
  • TABLE 5 BIOPSY DEVICES UNDER FDA’S REGULATION 21 CFR 876.1075
  • TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LIST OF PATENTS IN BIOPSY DEVICES MARKET, 2014−2024
  • TABLE 12 IMPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2023 (USD MILLION)
  • TABLE 13 EXPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2023 (USD MILLION)
  • TABLE 14 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021–2023 (USD)
  • TABLE 15 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION, 2021–2023 (USD)
  • TABLE 16 BIOPSY DEVICES MARKET: KEY CONFERENCES & EVENTS, 2025
  • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS
  • TABLE 18 KEY BUYING CRITERIA FOR KEY END USERS
  • TABLE 19 BIOPSY DEVICES MARKET: UNMET NEEDS
  • TABLE 20 BIOPSY DEVICES MARKET: EXPECTATIONS OF END USERS
  • TABLE 21 BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 22 BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 23 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 24 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,2024–2030 (USD MILLION)
  • TABLE 25 NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021–2023 (USD MILLION)
  • TABLE 26 NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024–2030 (USD MILLION)
  • TABLE 27 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 28 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 29 CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 30 CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 31 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 32 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 33 CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 34 CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 35 SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 36 SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 37 AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 38 AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 39 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 40 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 41 CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 42 CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 43 DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 44 DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 45 REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 46 REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 47 FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 48 FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 49 VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 50 VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 51 VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 52 VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 53 BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021–2023 (USD MILLION)
  • TABLE 54 BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024–2030 (USD MILLION)
  • TABLE 55 BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 56 BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 57 BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 58 BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 59 BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 60 BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 61 BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 62 BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 63 GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 64 GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 65 HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 66 HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 67 TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 68 TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 69 LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 70 LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 71 OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 72 OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 73 ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 74 ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 75 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 76 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 77 ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 78 ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 79 STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 80 STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 81 OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 82 OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 83 BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 84 BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 85 ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)
  • TABLE 86 ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)
  • TABLE 87 ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 88 ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 89 BREAST CANCER: BIOPSY DEVICES CANCER MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 90 BREAST CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 91 SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 92 SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 93 GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 94 GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 95 BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 96 BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 97 OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 98 OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 99 BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 100 BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 101 HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 102 HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 103 DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 104 DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 105 AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 106 AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 107 OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION)
  • TABLE 108 OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION)
  • TABLE 109 BIOPSY DEVICES MARKET, BY REGION, 2021–2023 (USD MILLION)
  • TABLE 110 BIOPSY DEVICES MARKET, BY REGION, 2024–2030 (USD MILLION)
  • TABLE 111 BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS)
  • TABLE 112 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 113 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 114 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 115 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 116 NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 117 NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 118 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 119 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 120 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 121 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 122 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 123 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 124 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 125 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 126 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 127 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 128 NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 129 NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 130 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 131 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 132 NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 133 NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 134 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 135 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 136 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS)
  • TABLE 137 US: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 138 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 139 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 140 US: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 141 US: BIOPSY DEVICES MARKET, BY NEEDLE BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 142 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 143 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 144 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 145 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 146 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 147 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 148 US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 149 US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 150 US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 151 US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 152 US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 153 US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 154 US: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 155 US: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 156 US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 157 US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 158 US: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 159 US: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 160 CANADA: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 161 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 162 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 163 CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 164 CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 165 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 166 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 167 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 168 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 169 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 170 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 171 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 172 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 173 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 174 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 175 CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 176 CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 177 CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 178 CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 179 CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 180 CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 181 CANADA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 182 CANADA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 183 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 184 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 185 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 186 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 187 EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 188 EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 189 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 190 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 191 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 192 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 193 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 194 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 195 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 196 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 197 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 198 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 199 EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 200 EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 201 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 202 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 203 EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 204 EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 205 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 206 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 207 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS)
  • TABLE 208 GERMANY: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 209 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 210 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 211 GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 212 GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 213 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 214 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 215 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 216 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 217 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 218 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 219 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 220 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 221 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 222 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 223 GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 224 GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 225 GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 226 GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 227 GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 228 GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 229 GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 230 GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 231 UK: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 232 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 233 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 234 UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 235 UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 236 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 237 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 238 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 239 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 240 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 241 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 242 UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 243 UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 244 UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 245 UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 246 UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 247 UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 248 UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 249 UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 250 UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 251 UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 252 UK: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 253 UK: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 254 FRANCE: MACRO-INDICATORS IMPACTING GROWTH
  • TABLE 255 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 256 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 257 FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 258 FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 259 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 260 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 261 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 262 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 263 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 264 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 265 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 266 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 267 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 268 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 269 FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 270 FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 271 FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 272 FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 273 FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 274 FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 275 FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 276 FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 277 ITALY: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 278 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 279 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 280 ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 281 ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 282 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 283 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 284 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 285 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 286 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 287 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 288 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 289 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 290 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 291 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 292 ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 293 ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 294 ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 295 ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 296 ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 297 ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 298 ITALY: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 299 ITALY: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 300 SPAIN: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 301 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 302 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 303 SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 304 SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 305 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 306 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 307 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 308 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 309 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 310 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 311 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 312 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 313 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 314 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 315 SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 316 SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 317 SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 318 SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 319 SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 320 SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 321 SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 322 SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 323 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 324 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 325 REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 326 REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 327 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 328 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 329 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 330 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 331 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 332 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 333 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 334 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 335 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 336 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 337 REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 338 REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 339 REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 340 REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION,2024–2030 (USD MILLION)
  • TABLE 341 REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 342 REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 343 REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 344 REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 345 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 346 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 347 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 348 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 349 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 350 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 351 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 352 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 353 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 354 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 355 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 356 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 357 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 358 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 359 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 360 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 361 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 362 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 363 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 364 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 365 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 366 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 367 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 368 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 369 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS)
  • TABLE 370 CHINA: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 371 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 372 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 373 CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 374 CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 375 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 376 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 377 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 378 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 379 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 380 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 381 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 382 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 383 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 384 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 385 CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 386 CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 387 CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 388 CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 389 CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 390 CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 391 CHINA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 392 CHINA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 393 JAPAN: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 394 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 395 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 396 JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 397 JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 398 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 399 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 400 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 401 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 402 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 403 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 404 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 405 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 406 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 407 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 408 JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 409 JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 410 JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 411 JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 412 JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 413 JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 414 JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 415 JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 416 INDIA: MACRO-INDICATORS IMPACTING GROWTH
  • TABLE 417 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 418 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 419 INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 420 INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 421 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 422 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 423 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 424 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 425 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 426 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 427 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 428 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 429 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 430 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 431 INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 432 INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 433 INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 434 INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 435 INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 436 INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 437 INDIA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 438 INDIA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 439 AUSTRALIA: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 440 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 441 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 442 AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 443 AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 444 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 445 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 446 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 447 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 448 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 449 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 450 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 451 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 452 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 453 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 454 AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 455 AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 456 AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 457 AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 458 AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 459 AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 460 AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 461 AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 462 SOUTH KOREA: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 463 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 464 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 465 SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 466 SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 467 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 468 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 469 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 470 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 471 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 472 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 473 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 474 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 475 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 476 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 477 SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 478 SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 479 SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 480 SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 481 SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 482 SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 483 SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 484 SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 485 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 486 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 487 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 488 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 489 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 490 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 491 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 492 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 493 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 494 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 495 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 496 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 497 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 498 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 499 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 500 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY,2024–2030 (USD MILLION)
  • TABLE 501 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 502 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 503 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 504 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 505 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 506 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 507 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 508 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 509 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 510 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 511 LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 512 LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 513 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 514 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 515 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 516 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 517 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 518 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 519 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 520 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 521 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 522 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 523 LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 524 LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 525 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 526 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 527 LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 528 LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 529 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 530 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 531 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS)
  • TABLE 532 BRAZIL: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 533 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 534 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 535 BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 536 BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 537 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 538 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 539 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 540 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 541 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 542 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 543 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 544 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 545 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 546 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 547 BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 548 BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 549 BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 550 BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 551 BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 552 BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 553 BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 554 BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 555 MEXICO: MACRO-INDICATORS IMPACTING MARKET
  • TABLE 556 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 557 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 558 MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 559 MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 560 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 561 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 562 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 563 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 564 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 565 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 566 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 567 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 568 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 569 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 570 MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 571 MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 572 MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 573 MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 574 MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 575 MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 576 MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 577 MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 578 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 579 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 580 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 581 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 582 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 583 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 584 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 585 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 586 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 587 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 588 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 589 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 590 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 591 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 592 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 593 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 594 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 595 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 596 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 597 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 598 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 599 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 600 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
  • TABLE 601 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
  • TABLE 602 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 603 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 604 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 605 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 606 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 607 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 608 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 609 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 610 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 611 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 612 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 613 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 614 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 615 MIDDLE EAST &AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 616 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 617 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 618 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 619 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 620 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 621 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 622 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 623 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 624 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS)
  • TABLE 625 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 626 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 627 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 628 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 629 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 630 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 631 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 632 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 633 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 634 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 635 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 636 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 637 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 638 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 639 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 640 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 641 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 642 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 643 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 644 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 645 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 646 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 647 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION)
  • TABLE 648 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION)
  • TABLE 649 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION)
  • TABLE 650 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION)
  • TABLE 651 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION)
  • TABLE 652 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION)
  • TABLE 653 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION)
  • TABLE 654 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION)
  • TABLE 655 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION)
  • TABLE 656 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION)
  • TABLE 657 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION)
  • TABLE 658 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION)
  • TABLE 659 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION)
  • TABLE 660 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION)
  • TABLE 661 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION)
  • TABLE 662 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION)
  • TABLE 663 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
  • TABLE 664 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
  • TABLE 665 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION)
  • TABLE 666 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION)
  • TABLE 667 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)
  • TABLE 668 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)
  • TABLE 669 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET
  • TABLE 670 BIOPSY DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 671 BIOPSY DEVICES MARKET: REGION FOOTPRINT
  • TABLE 672 BIOPSY DEVICES MARKET: PRODUCT FOOTPRINT
  • TABLE 673 BIOPSY DEVICES MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 674 BIOPSY DEVICES MARKET: APPLICATION FOOTPRINT
  • TABLE 675 BIOPSY DEVICES MARKET: END USER FOOTPRINT
  • TABLE 676 BIOPSY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 677 BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
  • TABLE 678 BIOPSY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 679 BIOPSY DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 680 BIOPSY DEVICES MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025
  • TABLE 681 BD (BECTON, DICKINSON AND COMPANY): COMPANY OVERVIEW
  • TABLE 682 BD (BECTON, DICKINSON AND COMPANY): PRODUCTS OFFERED
  • TABLE 683 BD (BECTON, DICKINSON AND COMPANY): DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 684 DEVICOR MEDICAL PRODUCTS, INC: COMPANY OVERVIEW
  • TABLE 685 DEVICOR MEDICAL PRODUCTS, INC: PRODUCTS OFFERED
  • TABLE 686 DEVICOR MEDICAL PRODUCTS, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 687 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 688 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 689 CARDINAL HEALTH: COMPANY OVERVIEW
  • TABLE 690 CARDINAL HEALTH: PRODUCTS OFFERED
  • TABLE 691 HOLOGIC, INC.: COMPANY OVERVIEW
  • TABLE 692 HOLOGIC, INC: PRODUCTS OFFERED
  • TABLE 693 HOLOGIC, INC: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 694 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 695 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 696 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 697 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 698 OLYMPUS CORPORATION: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 699 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 700 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 701 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 702 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 703 STRYKER: COMPANY OVERVIEW
  • TABLE 704 STRYKER: PRODUCTS OFFERED
  • TABLE 705 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 706 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 707 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 708 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 709 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
  • TABLE 710 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
  • TABLE 711 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
  • TABLE 712 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2021–JANUARY 2025
  • TABLE 713 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 714 JOHNSON & JOHNSON SERVICES INC.: PRODUCTS OFFERED
  • TABLE 715 COOK GROUP: COMPANY OVERVIEW
  • TABLE 716 COOK GROUP: PRODUCTS OFFERED
  • TABLE 717 COOK GROUP: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 5 TOP-DOWN APPROACH
  • FIGURE 6 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 7 BIOPSY DEVICES MARKET: CAGR PROJECTIONS
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 BIOPSY DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 10 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 11 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024 VS. 2030 (USD MILLION)
  • FIGURE 12 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024 VS. 2030 (USD MILLION)
  • FIGURE 13 BIOPSY DEVICES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 14 BIOPSY DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 16 RISING CASES OF CANCER TO DRIVE GLOBAL ADOPTION OF BIOPSY DEVICES
  • FIGURE 17 US AND HOSPITALS & BREAST CARE CENTERS SEGMENT ACCOUNTED FOR SIGNIFICANT SHARE IN 2023
  • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 19 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 20 DEVELOPING MARKET SEGMENT TO REGISTER HIGHER GROWTH THAN DEVELOPED MARKET SEGMENT BY 2030
  • FIGURE 21 BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 TRENDS IN BIOPSY DEVICES MARKET
  • FIGURE 23 BIOPSY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 24 NUMBER OF PATENTS PUBLISHED, 2014–2025
  • FIGURE 25 TOP TEN PATENT OWNERS FOR BIOPSY DEVICES, 2014−2025
  • FIGURE 26 TOP APPLICANTS FOR BIOPSY DEVICES, 2014−2025
  • FIGURE 27 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021–2023 (USD)
  • FIGURE 28 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION, 2021–2023 (USD)
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS
  • FIGURE 30 KEY BUYING CRITERIA FOR KEY END USERS
  • FIGURE 31 BIOPSY DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 32 BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 33 REVENUE SHIFT FOR BIOPSY DEVICES MARKET
  • FIGURE 34 INVESTMENT & FUNDING SCENARIO, 2019–2023 (USD MILLION)
  • FIGURE 35 USE OF AI/GEN AI IN BIOPSY PROCEDURES
  • FIGURE 36 NORTH AMERICA: BIOPSY DEVICES MARKET SNAPSHOT
  • FIGURE 37 ASIA PACIFIC: BIOPSY DEVICES MARKET SNAPSHOT
  • FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION)
  • FIGURE 39 MARKET SHARE ANALYSIS, 2023
  • FIGURE 40 RANKING OF KEY PLAYERS IN BIOPSY DEVICES MARKET, 2023
  • FIGURE 41 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 42 BIOPSY DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 43 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 45 EV/EBITDA OF KEY PLAYERS
  • FIGURE 46 BIOPSY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 47 BD (BECTON, DICKINSON AND COMPANY): COMPANY SNAPSHOT (2024)
  • FIGURE 48 DEVICOR MEDICAL PRODUCTS, INC: COMPANY SNAPSHOT (2023)
  • FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT (2024)
  • FIGURE 50 CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
  • FIGURE 51 HOLOGIC, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 52 B. BRAUN SE: COMPANY SNAPSHOT (2023)
  • FIGURE 53 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 54 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 55 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 56 STRYKER: COMPANY SNAPSHOT (2023)
  • FIGURE 57 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 58 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 59 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023)
  • FIGURE 60 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023)

 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global biopsy device market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the biopsy device market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents is provided below:

Biopsy Device Market

*C-level primaries include CEOs, CFOs, COOs, and VPs.

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global biopsy device equipment market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global biopsy device market was split into various segments and sub-segments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of various vaccine storage equipment manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from biopsy device (or the nearest reported business unit/product category)
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global biopsy device market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Market Size Estimation (Bottom Up approach & Top down approach)

Biopsy Device Market

Data Triangulation

After arriving at the overall size of the global biopsy device market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Biopsy devices are medical instruments used to extract tissue samples from the body for diagnostic examination, primarily to detect cancer, infections, or other diseases. These devices include biopsy needles, forceps, punches, and vacuum-assisted biopsy systems, commonly used in procedures such as needle biopsy, surgical biopsy, and endoscopic biopsy.

Stakeholders

  • Manufacturers of biopsy devices
  • Biopsy device distributors
  • Healthcare service providers
  • Various research associations related to biopsy devices
  • Research institutes
  • Venture capitalists and investors
  • Various research and consulting companies
  • World Health Organization (WHO)
  • Organization for Economic Co-operation and Development (OECD)
  • National Institutes of Health (NIH)
  • Centers for Disease Control and Prevention (CDC)
  • Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
  • White Papers, Journals/Magazines, and News Articles
  • Paid Databases, such as Factiva, D&B Hoovers, and Bloomberg Business

Report Objectives

  • To describe, analyze, and forecast the biopsy device market by product, by technology, by application, by end user, and region
  • To describe and forecast the biopsy device market in key regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the market growth
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile key players and comprehensively analyze their market shares and core competencies in the biopsy device market
  • To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the biopsy device market
  • To analyze the impact of AI/Gen AI on the biopsy device market in terms of its capabilities, potential, use cases, and future

Previous Versions of this Report

Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy), Guidance (Stereotactic, Ultrasound), End User (Hospital) & Region - Global Forecast to 2028

Report Code MD 5504
Published in Oct, 2023, By MarketsandMarkets™

Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy), Guidance (Stereotactic, Ultrasound), End User (Hospital) & Region - Global Forecast to 2028

Report Code MD 5504
Published in Aug, 2017, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Biopsy Devices Market

DMCA.com Protection Status